GNA15

GNA15 encodes Gα15, a Gq-class heterotrimeric G protein α-subunit that is restricted to hematopoietic lineages and functions as a promiscuous signal transducer coupling diverse GPCRs to multiple intracellular effector pathways (PMID:8838318, PMID:25701539, PMID:39656442). Gα15 physically couples to receptors including the β1-adrenergic receptor in neuroendocrine tumor cells and the adhesion GPCR CD312 (EMR2) in leukemia cells, activating downstream MAPK (ERK, JNK, p38), NF-κB, and Akt signaling to drive proliferation and suppress apoptosis (PMID:25701539, PMID:39656442). In thyroid carcinoma, GNA15 binds BTK and activates MAPK cascades to promote migration and invasion (PMID:38333922). In B-cell acute lymphoblastic leukemia, GNA15 upregulates AMPK-dependent fatty acid oxidation, conferring drug resistance that is partially reversed by the FAO inhibitor etomoxir (PMID:39812998).

1. 1996 High

   Defining GNA15 as a hematopoietic-restricted Gq-family paralog resolved its genomic identity and tissue specificity relative to the ubiquitous GNA11.

   Evidence Genomic cloning, gene structure characterization, and Northern blot in mouse and human tissues

   PMID:8838318

   Open questions at the time

   • No functional coupling to specific GPCRs demonstrated
   • Mechanism restricting expression to hematopoietic lineage not identified
   • No downstream signaling pathways mapped
2. 2002 Medium

   Genomic co-localization and co-expression of GNA15 and S1P4 suggested a functional receptor–G protein pairing, raising the question of whether Gα15 couples to S1P4 in vivo.

   Evidence Comparative genomic analysis and Northern blot in mouse and human tissues

   PMID:12401211

   Open questions at the time

   • Direct biochemical coupling between Gα15 and S1P4 was not demonstrated
   • Functional consequence of the tandem arrangement untested
3. 2015 Medium

   Demonstration that Gα15 couples to the β1-adrenergic receptor and drives ERK, NF-κB, and Akt signaling established it as a proliferative and survival signal transducer in neuroendocrine tumor cells.

   Evidence Co-immunoprecipitation, siRNA knockdown with proliferation/apoptosis assays and Western blot in KRJ-I cells

   PMID:25701539

   Open questions at the time

   • Single cell line tested; generalizability to other neuroendocrine tumors unknown
   • No direct enzymatic activity measurement of Gα15 GTPase function
   • Downstream effector mediating NF-κB activation not identified
4. 2023 Medium

   Identification of GNA15 as a target of exosomal miR-211-5p connected its regulation to intercellular communication and tumor immune microenvironment remodeling.

   Evidence miRNA target validation, exosome transfer assays, and glycolysis/pyroptosis functional assays in melanoma cells

   PMID:36642112

   Open questions at the time

   • Direct mechanism by which GNA15 protein controls pyroptosis or glycolysis not delineated
   • In vivo relevance of exosomal miR-211-5p regulation not confirmed
   • Primarily bioinformatic-driven with limited direct biochemical validation of GNA15 action
5. 2024 Medium

   Discovery that GNA15 physically binds BTK and that BTK is epistatic to GNA15-driven MAPK activation in thyroid carcinoma revealed a non-canonical effector mechanism for Gα15 signaling outside hematopoietic lineages.

   Evidence Co-IP, BTK knockdown and GNA15 rescue, proliferation/migration assays in thyroid carcinoma cell lines

   PMID:38333922

   Open questions at the time

   • Single lab; BTK–GNA15 interaction not validated by orthogonal structural or biophysical methods
   • Whether GNA15 activates BTK kinase activity directly or serves as a scaffold is unknown
   • Expression of GNA15 in non-hematopoietic thyroid tissue not reconciled with its known tissue restriction
6. 2024 Medium

   Establishing that the adhesion GPCR CD312/EMR2 signals through Gα15 to activate MAPK in leukemia cells broadened the receptor repertoire and confirmed Gα15 as a mediator of non-classical GPCR signaling in hematopoietic malignancy.

   Evidence Co-IP/affinity binding, GNA15 knockdown, BrdU proliferation assay, and Western blot in leukemia co-culture system

   PMID:39656442

   Open questions at the time

   • Structural basis of CD312–Gα15 transmembrane interaction not determined
   • Whether canonical Gq effector PLCβ is activated downstream of CD312–Gα15 coupling not tested
7. 2025 Medium

   Linking GNA15 to AMPK-dependent fatty acid oxidation and drug resistance in B-ALL defined a metabolic effector axis distinct from its established MAPK and NF-κB signaling roles.

   Evidence Metabolomics, GNA15 overexpression/knockdown, AMPK/FAO marker Western blot, and etomoxir rescue in leukemia cell lines

   PMID:39812998

   Open questions at the time

   • Mechanism connecting Gα15 GTPase activation to AMPK phosphorylation is unknown
   • In vivo drug resistance contribution not demonstrated
   • Whether FAO reprogramming is specific to B-ALL or a general Gα15 effector output is untested

• The direct GTPase-coupled effector interface of Gα15 — including whether it activates PLCβ, BTK, or AMPK through distinct or convergent mechanisms — remains structurally and biochemically unresolved.
• No crystal or cryo-EM structure of Gα15 alone or in complex with an effector
• GTPase kinetics and nucleotide specificity not measured directly
• Relative contributions of MAPK, NF-κB, Akt, and AMPK/FAO arms to in vivo physiology unknown